news
-
10 November 2021Sonendo's GentleWave Surpasses 700,000 Treatments, Solidifying Procedure as Alternative to Traditional Root Canal Therapy
Sonendo, Inc., (NYSE: SONX) a leading dental technology company and developer of the GentleWave® System, today announced it has treated over 700,000 patients with its GentleWave® System, an alternative to traditional root canal therapy (RCT) backed by years of research and peer-reviewed clinical outcomes. This milestone comes after the company's recent IPO on October 29, 2021.
"This major milestone coupled with our move to become a public company is a testament to years of research and innovation that have enabled our expansion and ability to serve 700,000 patients," said Bjarne Bergheim, president and CEO of Sonendo. "It is a very humbling experience to see the GentleWave procedure's positive impact on improving root canal efficacy, efficiency, and experience for patients and the clinicians who treat them. We look forward to the continued success of the treatment and reaching more doctors and patients."
The GentleWave System is an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of our GentleWave System when compared to conventional methods of RCT include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition to the clinical benefits, the GentleWave System can improve the workflow and economics of dental practices.
"The GentleWave System has made me fall in love again with the specialty of Endodontics," said Dr. Rick Simcock DDS, a practicing endodontist of 22 years. "The ease of use, predictability, and confidence in the results, has allowed me to feel that I am delivering the highest level of patient care. Being able to incorporate this technology into my busy and productive office, has allowed me to elevate my practice to new levels, while seeing high and rapid healing rates and improved post-operative treatment responses."
Patients interested in learning more about the GentleWave procedure, or to find providers, can visit www.gentlewave.com.
Related
Sonendo, Inc. Announces Pricing of Initial Public Offering
Sonendo, Inc. Announces Launch of Initial Public Offering
Sonendo®, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering
Sonendo® Acquires Portfolio of Novel Dental Procedure Technology Patents
Sonendo® Launches 500K Club Charitable Initiative
Sonendo® Reaches 500,000 Patients Treated Milestone with the GentleWave® Procedure
Sonendo® Appoints Amit Agarwal as Vice President of Marketing
Sonendo® Appoints Andrew Kirkpatrick as Chief Operating Officer
Sonendo® Announces Growth Investment from EW Healthcare Partners
Sonendo® Ships a Record 200,000 GentleWave® Procedure Instruments
Sonendo® to Launch the GentleWave® System in Canada at AAE 2019
Sonendo® and TDO® Software Expand Their Strategic Partnership
Sonendo® Named Fastest Growing Mid-Size Private Company in Orange County
Sonendo® Announces GentleWave® System Integration With TDO® Endodontic Software
Sonendo® Ships 50,000 GentleWave® Procedure Instruments to Endodontists
Sonendo® appoints Michael Watts as Chief Financial Officer
Sonendo® 2017 Red Herring Top 100 Global Winner
Sonendo® wins Octane High Tech Innovation Award
Sonendo® announces growth investment from General Atlantic
Sonendo® 2017 Red Herring Top 100 North America Winner In Medical Device Category
Sonendo® Acquires Pipstek™ LLC
Sonendo® Closes $35 Million Equity Financing Round
Sonendo® appoints John "Jack" Glenn as Chief Financial Officer
Prospective multicenter study shows remarkable healing rates with Sonendo's Gentlewave® System
Sonendo's GentleWave® System finalist in the 2016 Medical Design Excellence Awards
Sonendo® receives FDA 510(K) clearance for the next generation of the Gentlewave® System
Sonendo® Appoints Chief Commercial Officer
Sonendo® Appoints Vice President of Operations
Sonendo® Receives 510(k) FDA Clearance For Its Multisonic Ultracleaning™System
Sonendo® Closes $35 Million Equity Financing Round
Sonendo® Receives 510(k) FDA Clearance For Its Multisonic Ultracleaning System
Sonendo® Closes $10 Million Venture Debt Facility with Oxford Finance
Sonendo® Receives 510(k) FDA Clearance For Its Multisonic Ultracleaning System™
Sonendo completes second round totaling $27 million
Sonendo® Debuts New Endodontic Multisonic Ultracleaning™ System at AAE 2013 Hawaii
Sonendo Agrees To Terms For Up To $20 Million In Financing